HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trigeminal neuralgia treated by the injection of glycerol into the trigeminal cistern.

Abstract
Seventy-five patients with trigeminal neuralgia were treated by the injection of 0.2 to 0.4 ml of glycerol by the anterior percutaneous route into the trigeminal cistern, which was visualized by the aid of contrast medium (metrizamide). Eighty-six per cent of the patients were completely free from pain after the treatment, which produced only minimal disturbance of facial sensitivity. No complications have been observed. It is suggested that glycerol acts mainly on partly demyelinated nerve fibers, which are assumed to be involved in the trigger mechanism.
AuthorsS Håkanson
JournalNeurosurgery (Neurosurgery) Vol. 9 Issue 6 Pg. 638-46 (Dec 1981) ISSN: 0148-396X [Print] United States
PMID7322329 (Publication Type: Journal Article)
Chemical References
  • Glycerol
  • Metrizamide
Topics
  • Aged
  • Glycerol (administration & dosage)
  • Humans
  • Injections (methods)
  • Metrizamide
  • Radiography
  • Sensation
  • Trigeminal Nerve (diagnostic imaging)
  • Trigeminal Neuralgia (diagnosis, diagnostic imaging, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: